These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8732663)

  • 1. Quality assurance cytology error tracking system for negative GYN case rescreen.
    Maloney JA
    Diagn Cytopathol; 1996 May; 14(3):282-3. PubMed ID: 8732663
    [No Abstract]   [Full Text] [Related]  

  • 2. Weekly rescreening of 10% of the total cervical Papanicolaou smears: a worthwhile quality assurance scheme.
    Sampatanukul P; Wannakrairot P; Promprakob U; Yodavudh S; Anansiriprapa C
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S261-5. PubMed ID: 16083199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic variability versus diagnostic errors in cytology].
    Dalla Palma P
    Pathologica; 2001 Oct; 93(5):593-5. PubMed ID: 11725366
    [No Abstract]   [Full Text] [Related]  

  • 4. Quality and liability issues with the Papanicolaou smear: the problem of definition of errors and false-negative smears.
    Davey DD
    Arch Pathol Lab Med; 1997 Mar; 121(3):267-9. PubMed ID: 9111115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing the error rate in Papanicolaou smears. One laboratory's experience with the PAPNET system.
    Koss LG
    Physician Assist; 1994 Dec; 18(12):48-52. PubMed ID: 10139375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Errors in cervical smears: minimizing the risk of medicolegal consequences.
    Greening SE
    Monogr Pathol; 1997; (39):16-39. PubMed ID: 9249818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality and liability issues with the Papanicolaou smear: lessons from the science of error prevention.
    Derman H
    Arch Pathol Lab Med; 1997 Mar; 121(3):287-91. PubMed ID: 9111120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guidelines for the evaluation of internal quality control of smears for screening of uterine cancer in France in the structures of Pathologic Anatomy and Cytology. French Association for Quality Assurance in Pathologic Anatomy and Cytology (AFAQAP)--Commission for cervical smears].
    Albuisson F; Anger E; Baron V; Cartier I; Dorne H; Dubois-Gordeff A; Hassoun J; Jouannelle A; Labbé S; Locquet D; Marsan C; Martin E; Michiels-Marzias D; Molinié V; Mottot C; Mueller B; Vacher-Lavenu MC; Vincent S; Vuong PN
    Ann Pathol; 1998 Jul; 18(3):221-6. PubMed ID: 9750045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An operative model: verification of the quality of the screening Pap test ].
    Montanari GR; Arnaud S; Berardengo E; Campione D; Cozzani C; Parisio F; Viberti L; Ghiringhello B
    Pathologica; 2001 Oct; 93(5):609-10. PubMed ID: 11725370
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving Papanicolaou test quality and reducing medical errors by using Toyota production system methods.
    Raab SS; Andrew-Jaja C; Condel JL; Dabbs DJ
    Am J Obstet Gynecol; 2006 Jan; 194(1):57-64. PubMed ID: 16389010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality control and automation in cervical cytology.
    Kumar N; Jain S
    J Indian Med Assoc; 2004 Jul; 102(7):372, 374, 376 pasim. PubMed ID: 15717583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
    Renshaw A
    Cancer; 2006 Aug; 108(4):267; author reply 268. PubMed ID: 16671112
    [No Abstract]   [Full Text] [Related]  

  • 13. [Automation of cytological analysis of cervical smears].
    Cenci M; Giovagnoli MR; Olla SV; Drusco A; Vecchione A
    Minerva Ginecol; 1999; 51(7-8):291-8. PubMed ID: 10536424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Companies build Pap smear safety nets.
    Scott L
    Mod Healthc; 1995 May; 25(19):70. PubMed ID: 10142267
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategies for reducing Papanicolaou smear screening errors: principles derived from data and experience with quality control.
    Krieger PA
    Arch Pathol Lab Med; 1997 Mar; 121(3):277-81. PubMed ID: 9111118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
    Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
    Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitfalls in diagnostic cervicovaginal cytology.
    Sidawy MK; Solomon D
    Monogr Pathol; 1997; (39):1-15. PubMed ID: 9249817
    [No Abstract]   [Full Text] [Related]  

  • 18. The gynecologist's perspective of liability and quality issues with the Papanicolaou smear.
    Greer BE
    Arch Pathol Lab Med; 1997 Mar; 121(3):246-9. PubMed ID: 9111109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of reporting endocervical component adequacy--a continuous quality improvement project.
    Roberson J; Connolly K; St John K; Eltoum I; Chhieng DC
    Diagn Cytopathol; 2002 Sep; 27(3):181-4. PubMed ID: 12203868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
    Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
    Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.